Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 94

1.

Rethinking risk for pneumococcal disease in adults: the role of risk stacking.

Pelton SI, Shea KM, Weycker D, Farkouh RA, Strutton DR, Edelsberg J.

Open Forum Infect Dis. 2015 Mar 20;2(1):ofv020. doi: 10.1093/ofid/ofv020. eCollection 2015 Jan.

2.

Rates of pneumococcal disease in adults with chronic medical conditions.

Shea KM, Edelsberg J, Weycker D, Farkouh RA, Strutton DR, Pelton SI.

Open Forum Infect Dis. 2014 May 27;1(1):ofu024. doi: 10.1093/ofid/ofu024. eCollection 2014 Mar.

3.

Risk and Consequences of Chemotherapy-Induced Febrile Neutropenia in Patients With Metastatic Solid Tumors.

Weycker D, Li X, Edelsberg J, Barron R, Kartashov A, Xu H, Lyman GH.

J Oncol Pract. 2014 Dec 9. pii: JOP.2014.001492. [Epub ahead of print]

PMID:
25491042
4.

Risk of febrile neutropenia in patients receiving emerging chemotherapy regimens.

Weycker D, Li X, Edelsberg J, Barron R, Kartashov A, Xu H, Lyman GH.

Support Care Cancer. 2014 Dec;22(12):3275-85. doi: 10.1007/s00520-014-2362-5. Epub 2014 Aug 1.

PMID:
25082364
5.

Prevention of group B streptococcal disease in the first 3 months of life: would routine maternal immunization during pregnancy be cost-effective?

Oster G, Edelsberg J, Hennegan K, Lewin C, Narasimhan V, Slobod K, Edwards MS, Baker CJ.

Vaccine. 2014 Aug 20;32(37):4778-85. doi: 10.1016/j.vaccine.2014.06.003. Epub 2014 Jun 30.

PMID:
24992717
6.

Risk of pneumococcal disease in children with chronic medical conditions in the era of pneumococcal conjugate vaccine.

Pelton SI, Weycker D, Farkouh RA, Strutton DR, Shea KM, Edelsberg J.

Clin Infect Dis. 2014 Sep 1;59(5):615-23. doi: 10.1093/cid/ciu348. Epub 2014 May 13.

7.

Clinical and economic consequences of post-operative infections following major elective surgery in U.S. hospitals.

Berger A, Edelsberg J, Yu H, Oster G.

Surg Infect (Larchmt). 2014 Jun;15(3):322-7. doi: 10.1089/sur.2012.200. Epub 2014 May 1.

PMID:
24786660
8.

Risk and consequences of chemotherapy-induced neutropenic complications in patients receiving daily filgrastim: the importance of duration of prophylaxis.

Weycker D, Barron R, Edelsberg J, Kartashov A, Legg J, Glass AG.

BMC Health Serv Res. 2014 Apr 27;14:189. doi: 10.1186/1472-6963-14-189.

9.

Use of intravenous bisphosphonates in patients with breast, lung, or prostate cancer and metastases to bone: a 15-year study in two large US health systems.

Oster G, Lamerato L, Glass AG, Richert-Boe KE, Lopez A, Chung K, Richhariya A, Dodge T, Wolff GG, Balakumaran A, Edelsberg J.

Support Care Cancer. 2014 May;22(5):1363-73. doi: 10.1007/s00520-013-2094-y. Epub 2014 Jan 4.

PMID:
24389827
10.

Prevalence of antibiotic resistance in US hospitals.

Edelsberg J, Weycker D, Barron R, Li X, Wu H, Oster G, Badre S, Langeberg WJ, Weber DJ.

Diagn Microbiol Infect Dis. 2014 Mar;78(3):255-62. doi: 10.1016/j.diagmicrobio.2013.11.011. Epub 2013 Nov 15.

PMID:
24360267
11.

Patterns of initial antibiotic therapy for community-acquired pneumonia in U.S. hospitals, 2000 to 2009.

Berger A, Edelsberg J, Oster G, Huang X, Weber DJ.

Am J Med Sci. 2014 May;347(5):347-56. doi: 10.1097/MAJ.0b013e318294833f.

PMID:
24029796
12.

Natural history of skeletal-related events in patients with breast, lung, or prostate cancer and metastases to bone: a 15-year study in two large US health systems.

Oster G, Lamerato L, Glass AG, Richert-Boe KE, Lopez A, Chung K, Richhariya A, Dodge T, Wolff GG, Balakumaran A, Edelsberg J.

Support Care Cancer. 2013 Dec;21(12):3279-86. doi: 10.1007/s00520-013-1887-3. Epub 2013 Jul 25.

PMID:
23884473
13.

Initial treatment failure in patients with complicated skin and skin structure infections.

Berger A, Oster G, Edelsberg J, Huang X, Weber DJ.

Surg Infect (Larchmt). 2013 Jun;14(3):304-12. doi: 10.1089/sur.2012.103. Epub 2013 Apr 16.

PMID:
23590851
14.

Initial treatment failure in non-ICU community-acquired pneumonia: risk factors and association with length of stay, total hospital charges, and mortality.

Oster G, Berger A, Edelsberg J, Weber DJ.

J Med Econ. 2013;16(6):809-19. doi: 10.3111/13696998.2013.794805. Epub 2013 May 15.

PMID:
23574431
15.

Technical evaluation of methods for identifying chemotherapy-induced febrile neutropenia in healthcare claims databases.

Weycker D, Sofrygin O, Seefeld K, Deeter RG, Legg J, Edelsberg J.

BMC Health Serv Res. 2013 Feb 13;13:60. doi: 10.1186/1472-6963-13-60.

16.

Cost-effectiveness of adult pneumococcal vaccination: response to Grabenstein et al.

Weycker D, Sato R, Strutton D, Edelsberg J, Atwood M, Jackson LA.

Vaccine. 2013 Apr 19;31(17):2109. doi: 10.1016/j.vaccine.2013.01.008. Epub 2013 Jan 11. No abstract available.

PMID:
23318148
17.

Prophylaxis against venous thromboembolism in hospitalized medically ill patients.

Pendergraft T, Liu X, Edelsberg J, Phatak H, Vera-Llonch M, Liu LZ, Oster G.

Circ Cardiovasc Qual Outcomes. 2013 Jan 1;6(1):75-82. doi: 10.1161/CIRCOUTCOMES.112.965939. Epub 2013 Jan 8.

18.

Changes in healthcare utilization and costs associated with sildenafil therapy for pulmonary arterial hypertension: a retrospective cohort study.

Berger A, Edelsberg J, Teal S, Mychaskiw MA, Oster G.

BMC Pulm Med. 2012 Dec 11;12:75. doi: 10.1186/1471-2466-12-75.

19.

[Generalized anxiety disorder in primary care. Patterns of healthcare utilization in Germany].

Wittchen HU, Härtling S, Dukes E, Morlock R, Edelsberg J, Oster G, Berger A.

MMW Fortschr Med. 2012 Oct 4;154 Suppl 3:77-84. German.

PMID:
23133883
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk